The BCKDK inhibitor BT2 is a chemical uncoupler that lowers mitochondrial ROS production and de novo lipogenesis. Acevedo, A., Jones, A. E., Danna, B. T., Turner, R., Montales, K. P., Benincá, C., Reue, K., Shirihai, O. S., Stiles, L., Wallace, M., Wang, Y., Bertholet, A. M., & Divakaruni, A. S. (2024). J Biol Chem, 300(3), 105702. (opens in a new window)https://doi.org/10.1016/j.jbc.2024.105702
Laxative Properties of Microencapsulated Oleic Acid Delivered to the Distal Small Intestine in Patients with Constipation after Bariatric Surgery or Treatment with Glucagon-Like- Peptide 1 Analogues. Al-Humadi, A. W., Al-Najim, W., Bleiel, S., & le Roux, C. W. (2024). Obes Surg, 34(10), 3807-3812. (opens in a new window)https://doi.org/10.1007/s11695-024-07492-y
Liver fibrosis and liver stiffness in patients with obesity and type 1 diabetes. Al-Ozairi, E., Irshad, M., AlKandari, J., Mashankar, A., Alroudhan, D., & le Roux, C. W. (2024). Diabetes Obes Metab, 26(9), 4052-4059. (opens in a new window)https://doi.org/10.1111/dom.15760
Reformulating ice cream to improve postprandial glucose response: an opportunity for industry to create shared value. Al-Ozairi, E., Mandani, Y., Alfaleh, G., Raj, J., Alshammari, S., & Le Roux, C. W. (2024). Front Nutr, 11, 1349392. (opens in a new window)https://doi.org/10.3389/fnut.2024.1349392
Obesity Treatments to Improve Type 1 Diabetes (OTID): a randomized controlled trial of the combination of glucagon-like peptide 1 analogues and sodium-glucose cotransporter 2 inhibitors-protocol for Obesity Treatments to Improve Type 1 Diabetes (the OTID trial). Al-Ozairi, E., Narula, K., Miras, A. D., Taghadom, E., Samad, A. E., Al Kandari, J., Alyosef, A., Mashankar, A., Al-Najim, W., & le Roux, C. W. (2024). Trials, 25(1), 129. (opens in a new window)https://doi.org/10.1186/s13063-024-07930-3
Prevalence of obesity in people with and without type 1 diabetes across Belgium, Kuwait, and Mexico: an IMI2 SOPHIA study. Al Ozairi, E., Steenackers, N., Pazmino, S., Alattar, A. T., Al Kandari, J., Almeda-Valdes, P., Antonio-Villa, N. E., Delfin, C., Faradji, R. N., García-Tuomola, A. A., Irshad, M., Longenecker, J. C., Rosen, J., Hurtado Del Pozo, C., Sparsø, T., Lavens, A., Mathieu, C., Van der Schueren, B., & le Roux, C. W. (2024). EClinicalMedicine, 77, 102869. (opens in a new window)https://doi.org/10.1016/j.eclinm.2024.102869
Weight loss response in patients with obesity treated with injectable semaglutide in a real-world setting. Alabduljabbar, K., Alsaqaaby, M., Neff, K. J., Crotty, M., & le Roux, C. W. (2024). Endocrine, 83(2), 392-398. (opens in a new window)https://doi.org/10.1007/s12020-023-03534-0
Perceived Benefits of Bariatric Surgery: Patient Perspectives. Alsaqaaby, M. S., Alabduljabbar, K. A., Alruwaili, H. R., Neff, K. J., Heneghan, H. M., Pournaras, D. J., & Le Roux, C. W. (2024). Obes Surg, 34(2), 583-591. (opens in a new window)https://doi.org/10.1007/s11695-023-07030-2
Sex, race, and BMI in clinical trials of medications for obesity over the past three decades: a systematic review. Alsaqaaby, M. S., Cooney, S., le Roux, C. W., & Pournaras, D. J. (2024). Lancet Diabetes Endocrinol, 12(6), 414-421. (opens in a new window)https://doi.org/10.1016/s2213-8587(24)00098-6
The Effects of Sleeve Gastrectomy on the Appetitive Domain of Taste Using the Progressive Ratio Task. Althukair, N. K., Abdeen, G. N., le Roux, C. W., Miras, A. D., & Alqahtani, A. R. (2024). Obes Surg, 34(4), 1168-1173. (opens in a new window)https://doi.org/10.1007/s11695-023-07035-x
Resmetirom and Metabolic Dysfunction-Associated Steatohepatitis: Perspectives on Multidisciplinary Management from Global Healthcare Professionals. Au, K., Zheng, M. H., Lee, W. J., Ghanem, O. M., Mahawar, K., Shabbir, A., le Roux, C. W., Targher, G., Byrne, C. D., Yilmaz, Y., Valenti, L., Sebastiani, G., Treeprasertsuk, S., Hui, H. X., Sakran, N., Neto, M. G., Kermansaravi, M., Kow, L., Seki, Y., Tham, K. W., Dang, J., Cohen, R. V., Stier, C., AlSabah, S., Oviedo, R. J., Chiappetta, S., Parmar, C., & Yang, W. (2024). Curr Obes Rep, 13(4), 818-830. (opens in a new window)https://doi.org/10.1007/s13679-024-00582-z
Changes in food preferences and ingestive behaviors after glucagon-like peptide-1 analog treatment: techniques and opportunities. Bettadapura, S., Dowling, K., Jablon, K., Al-Humadi, A. W., & le Roux, C. W. (2024). Int J Obes (Lond). (opens in a new window)https://doi.org/10.1038/s41366-024-01500-y
Exploring real-time functional magnetic resonance imaging neurofeedback in adolescents with disruptive behavior disorder and callous unemotional traits. Böttinger, B. W., Aggensteiner, P. M., Hohmann, S., Heintz, S., Ruf, M., Glennon, J., Holz, N. E., Banaschewski, T., Brandeis, D., & Baumeister, S. (2024). J Affect Disord, 345, 32-42. (opens in a new window)https://doi.org/10.1016/j.jad.2023.10.036
Determination of the Protein and Amino Acid Content of Fruit, Vegetables and Starchy Roots for Use in Inherited Metabolic Disorders. Boyle, F., Lynch, G., Reynolds, C. M., Green, A., Parr, G., Howard, C., Knerr, I., & Rice, J. (2024). Nutrients, 16(17). (opens in a new window)https://doi.org/10.3390/nu16172812
Real world use of tirzepatide in the treatment of type 2 diabetes in an Arab population. Buckley, A., Suliman, S., Allum, M., Mohammed, N., Lessan, N., le Roux, C. W., & Suliman, M. (2024). Diabetes Obes Metab, 26(8), 3381-3391. (opens in a new window)https://doi.org/10.1111/dom.15680
Genetic variants affecting mitochondrial function provide further insights for kidney disease. Cañadas-Garre, M., Baños-Jaime, B., Maqueda, J. J., Smyth, L. J., Cappa, R., Skelly, R., Hill, C., Brennan, E. P., Doyle, R., Godson, C., Maxwell, A. P., & McKnight, A. J. (2024). BMC Genomics, 25(1), 576. (opens in a new window)https://doi.org/10.1186/s12864-024-10449-1
Mitochondrial related variants associated with cardiovascular traits. Cañadas-Garre, M., Maqueda, J. J., Baños-Jaime, B., Hill, C., Skelly, R., Cappa, R., Brennan, E., Doyle, R., Godson, C., Maxwell, A. P., & McKnight, A. J. (2024). Front Physiol, 15, 1395371. (opens in a new window)https://doi.org/10.3389/fphys.2024.1395371
Obesity is South Africa's new HIV epidemic. Chandiwana, N., Venter, W., Manne-Goehler, J., Wade, A., Le Roux, C., Mbalati, N., Grimbeek, A., Kruger, P., Montsho, E., Zimela, Z., Yawa, A., Tshabalala, S., Rambau, N., Mpofu, N., Stevenson, S., McNulty, B., Ntusi, N., Pillay, Y., Dave, J., Murphy, A., Goldstein, S., Hfman, K., Mahomedy, S., Thomas, E., Mrara, B., Wing, J., Lubbe, J., Koto, Z., Conradie-Smit, M., Wharton, S., May, W., Marr, I., Kaplan, H., Forgan, M., Alexander, G., Turner, J., Fourie, V. R., Hellig, J., Banks, M., Ragsdale, K., Noeth, M., Mohamed, F., Myer, L., Lebina, L., Maswime, S., Moosa, Y., Thomas, S., Mbelle, M., Sinxadi, P., Bekker, L. G., Bhana, S., Fabian, J., Decloedt, E., Bayat, Z., Daya, R., Bobat, B., Storie, F., Goedecke, J., Kahn, K., Tollman, S., Mansfield, B., Siedner, M., Marconi, V., Mody, A., Mtshali, N., Geng, E., Srinivasa, S., Ali, M., Lalla-Edwards, S., Bentley, A., Wolvaardt, G., Hill, A., & Nel, J. (2024). S Afr Med J, 114(3), e1927. (opens in a new window)https://doi.org/10.7196/SAMJ.2024.v114i3.1927
Metabolic/Bariatric Surgery is Safe and Effective in People with Obesity, Type 2 Diabetes Mellitus and Chronic Kidney Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Cohen, R. V., Azevedo, M. A., Le Roux, C. W., Caldeon, L. P., Luque, A., Fayad, D. A., & Petry, T. B. Z. (2024). Obes Surg, 34(11), 4097-4105. (opens in a new window)https://doi.org/10.1007/s11695-024-07535-4
The role of nanosystems in the delivery of glucose-lowering drugs for the preemption and treatment of diabetes-associated atherosclerosis. Conroy, L. J., McCann, A., Zhang, N., & de Gaetano, M. (2024). Am J Physiol Cell Physiol, 326(5), C1398-c1409. (opens in a new window)https://doi.org/10.1152/ajpcell.00695.2023
Health Benefits Beyond the Scale: The Role of Diet and Nutrition During Weight Loss Programmes. Contreras, F., Al-Najim, W., & le Roux, C. W. (2024). Nutrients, 16(21). (opens in a new window)https://doi.org/10.3390/nu16213585
Subclassification of obesity for precision prediction of cardiometabolic diseases. Coral, D. E., Smit, F., Farzaneh, A., Gieswinkel, A., Tajes, J. F., Sparsø, T., Delfin, C., Bauvain, P., Wang, K., Temprosa, M., De Cock, D., Blanch, J., Fernández-Real, J. M., Ramos, R., Ikram, M. K., Gomez, M. F., Kavousi, M., Panova-Noeva, M., Wild, P. S., van der Kallen, C., Adriaens, M., van Greevenbroek, M., Arts, I., Le Roux, C., Ahmadizar, F., Frayling, T. M., Giordano, G. N., Pearson, E. R., & Franks, P. W. (2024). Nat Med. (opens in a new window)https://doi.org/10.1038/s41591-024-03299-7
Patient perspectives about treatment preferences for obesity with complications. Craig, H. C., Alsaeed, D., Norris, S., Holian, J., Kennedy, C., Feldman, A., & Le Roux, C. (2024). Obes Sci Pract, 10(1), e720. (opens in a new window)https://doi.org/10.1002/osp4.720
What influences patient decisions when selecting an obesity treatment? Craig, H. C., Walley, D., & le Roux, C. W. (2024). Obes Pillars, 12, 100123. (opens in a new window)https://doi.org/10.1016/j.obpill.2024.100123
Tirzepatide Reduces 24-Hour Ambulatory Blood Pressure in Adults With Body Mass Index ≥27 kg/m(2): SURMOUNT-1 Ambulatory Blood Pressure Monitoring Substudy. de Lemos, J. A., Linetzky, B., le Roux, C. W., Laffin, L. J., Vongpatanasin, W., Fan, L., Hemmingway, A., Ahmad, N. N., Bunck, M. C., & Stefanski, A. (2024). Hypertension, 81(4), e41-e43. (opens in a new window)https://doi.org/10.1161/hypertensionaha.123.22022
Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial. Deanfield, J., Verma, S., Scirica, B. M., Kahn, S. E., Emerson, S. S., Ryan, D., Lingvay, I., Colhoun, H. M., Plutzky, J., Kosiborod, M. N., Hovingh, G. K., Hardt-Lindberg, S., Frenkel, O., Weeke, P. E., Rasmussen, S., Goudev, A., Lang, C. C., Urina-Triana, M., Pietilä, M., & Lincoff, A. M. (2024). Lancet, 404(10454), 773-786. (opens in a new window)https://doi.org/10.1016/s0140-6736(24)01498-3
A Federated Database for Obesity Research: An IMI-SOPHIA Study. Delfin, C., Dragan, I., Kuznetsov, D., Tajes, J. F., Smit, F., Coral, D. E., Farzaneh, A., Haugg, A., Hungele, A., Niknejad, A., Hall, C., Jacobs, D., Marek, D., Fraser, D. P., Thuillier, D., Ahmadizar, F., Mehl, F., Pattou, F., Burdet, F., Hawkes, G., Arts, I. C. W., Blanch, J., Van Soest, J., Fernández-Real, J. M., Boehl, J., Fink, K., van Greevenbroek, M. M. J., Kavousi, M., Minten, M., Prinz, N., Ipsen, N., Franks, P. W., Ramos, R., Holl, R. W., Horban, S., Duarte-Salles, T., Tran, V. D. T., Raverdy, V., Leal, Y., Lenart, A., Pearson, E., Sparsø, T., Giordano, G. N., Ioannidis, V., Soh, K., Frayling, T. M., Le Roux, C. W., & Ibberson, M. (2024). Life (Basel), 14(2). (opens in a new window)https://doi.org/10.3390/life14020262
Tumour stemness and poor clinical outcomes in haemochromatosis patients with hepatocellular carcinoma. Di Capua, D. M., Shanahan, W., Bourke, M., Ramlaul, N., Appel, J., Canney, A., Docherty, N. G., McGrath, E., Ring, E., Jones, F., Boyle, M., McCormack, J., Gallagher, T., Hoti, E., Nolan, N., Ryan, J. D., Houlihan, D. D., & Fabre, A. (2024). J Clin Pathol, 77(10), 669-675. (opens in a new window)https://doi.org/10.1136/jcp-2022-208679
Reframing acute kidney injury as a pathophysiological continuum of disrupted renal excretory function. Docherty, N. G., Delles, C., & López-Hernández, F. J. (2024). Acta Physiol (Oxf), 240(8), e14181. (opens in a new window)https://doi.org/10.1111/apha.14181
The effects of saturated fat intake from dairy on CVD markers: the role of food matrices. Dunne, S., Gibney, E. R., McGillicuddy, F. C., & Feeney, E. L. (2024). Proc Nutr Soc, 1-9. (opens in a new window)https://doi.org/10.1017/s0029665124000132
Global barriers to decision makers for prioritizing interventions for obesity. Ehlers, L. H., Reinstrup, N. W., Olesen, R. H., Holm, J. C., McEwan, P., & Le Roux, C. W. (2024). Int J Obes (Lond). (opens in a new window)https://doi.org/10.1038/s41366-024-01650-z
Continuous glucose monitoring and low-glycaemic index diet in the management of postprandial hypoglycaemia after oesophagogastric cancer surgery. Fanning, M., Murphy, C. F., Elliott, J. A., Ravi, N., Docherty, N. G., le Roux, C. W., Donohoe, C. L., & Reynolds, J. V. (2024). Br J Surg, 111(1). (opens in a new window)https://doi.org/10.1093/bjs/znad371
Patient perspectives on personalised medicine for obesity: An IMI2 SOPHIA Study. Farrell, E., le Roux, C. W., Hollmann, E., Nadglowski, J., & McGillicuddy, D. (2024). Obes Res Clin Pract, 18(3), 216-221. (opens in a new window)https://doi.org/10.1016/j.orcp.2024.06.004
"What would be left of me?" Patient perspectives on the risks of obesity treatment: An innovative health initiative stratification of obesity phenotypes to optimise future obesity therapy (IMI2 SOPHIA) qualitative study. Farrell, E., Nadglowski, J., Hollmann, E., le Roux, C. W., & McGillicuddy, D. (2024). Obes Pillars, 12, 100129. (opens in a new window)https://doi.org/10.1016/j.obpill.2024.100129
Cortical structure and subcortical volumes in conduct disorder: a coordinated analysis of 15 international cohorts from the ENIGMA-Antisocial Behavior Working Group. Gao, Y., & Staginnus, M. (2024). Lancet Psychiatry, 11(8), 620-632. (opens in a new window)https://doi.org/10.1016/s2215-0366(24)00187-1
Altered sphingolipid biosynthetic flux and lipoprotein trafficking contribute to trans-fat-induced atherosclerosis. Gengatharan, J. M., Handzlik, M. K., Chih, Z. Y., Ruchhoeft, M. L., Secrest, P., Ashley, E. L., Green, C. R., Wallace, M., Gordts, P., & Metallo, C. M. (2024). Cell Metab. (opens in a new window)https://doi.org/10.1016/j.cmet.2024.10.016
The dual role of lipids in chronic kidney disease: Pathogenic culprits and therapeutic allies. Giardini, E., Moore, D., Sadlier, D., Godson, C., & Brennan, E. (2024). Atherosclerosis, 398, 118615. (opens in a new window)https://doi.org/10.1016/j.atherosclerosis.2024.118615
Long-term weight outcomes in patients treated with liraglutide 3.0 mg in real-world clinical practice. Grannell, A., Al-Najim, W., & le Roux, C. (2024). Clin Obes, 14(1), e12622. (opens in a new window)https://doi.org/10.1111/cob.12622